Internal Medicine · Bronx, NY
NPI
1861460818
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2015 Grand Concourse
Bronx, NY, 10453
Phone (718) 299-7295
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
2,977 services
Medicare patients, 2024
304
Average age 82
Drug cost, 2024
$1.1M
18,330 prescriptions
Company payments, 2025
$413
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Win Myint was code 99309 (snf e&m), 1,904 times for 239 patients. In total Win Myint billed 2,977 services in 7 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,904 | 239 | $90.90 | $173K |
| 99308 SNF E&M | Facility | 815 | 229 | $64.10 | $52K |
| 99306 SNF E&M | Facility | 114 | 98 | $160.45 | $18K |
| 99497 Care Management/Coordination | Facility | 91 | 91 | $66.72 | $6,072 |
| 99316 SNF E&M | Facility | 49 | 48 | $106.59 | $5,223 |
By year: 2022 $119K for 1,784 services; 2023 $187K for 2,114 services; 2024 $255K for 2,977 services.
Medicare prescription drug claims, 2024
In 2024, the drug Win Myint prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,448 prescriptions and refills. In total Win Myint wrote 18,330 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,448 | 1,452 | 166 | $20K |
| Amlodipine Besylate Generic | 877 | 883 | 101 | $7,126 |
| Eliquis Apixaban | 744 | 744 | 57 | $218K |
| Levothyroxine Sodium Generic | 654 | 654 | 65 | $8,186 |
| Lisinopril Generic | 632 | 632 | 49 | $6,157 |
| Mirtazapine Generic | 573 | 573 | 54 | $11K |
| Gabapentin Generic | 569 | 573 | 65 | $9,839 |
| Metoprolol Tartrate Generic | 453 | 453 | 52 | $4,257 |
| Metoprolol Succinate Generic | 452 | 456 | 57 | $6,874 |
| Tamsulosin Hcl Generic | 380 | 382 | 50 | $5,891 |
| Furosemide Generic | 364 | 368 | 54 | $2,375 |
| Clopidogrel Clopidogrel Bisulfate | 318 | 320 | 32 | $4,011 |
| Donepezil Hcl Generic | 289 | 289 | 33 | $3,858 |
| Memantine Hcl Generic | 287 | 287 | 30 | $11K |
| Metformin Hcl Generic | 256 | 258 | 33 | $2,687 |
Brand drugs: 2,641 claims; generic drugs: 15,584 claims; opioid claims: 247.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Win Myint $413 ($413 in general payments such as food, travel and fees) from 2 companies. The largest payer was Neurocrine BioSciences, Inc. with $292.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.